C. Irkkan Et Al. , "Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers," APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9, pp.609-614, 2017
Irkkan, C. Et Al. 2017. Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9 , 609-614.
Irkkan, C., Balci, S., Tezel, G. G., Akinci, B., Yalcin, B., & GÜLER, G., (2017). Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9, 609-614.
Irkkan, Cigdem Et Al. "Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers," APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9, 609-614, 2017
Irkkan, Cigdem Et Al. "Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers." APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9, pp.609-614, 2017
Irkkan, C. Et Al. (2017) . "Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers." APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9, pp.609-614.
@article{article, author={Cigdem Irkkan Et Al. }, title={Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers}, journal={APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY}, year=2017, pages={609-614} }